McKesson Corporation Revenues
Revenues of McKesson Corporation 2005-2021
Amounts are in $millions.
| Year | Revenues ($millions) |
| 2022 | $263,966 |
| 2021 | $238,228 |
| 2020 | $231,051 |
| 2019 | $ 214,319 |
| 2018 | $ 208,357 |
| 2017 | $ 198,533 |
| 2016 | $ 190,884 |
| 2015 | $ 179,045 |
| 2014 | $ 137,392 |
| 2013 | $ 122,196 |
| 2012 | $ 122,453 |
| 2011 | $ 111,804 |
| 2010 | $ 108,295 |
| 2009 | $ 106,632 |
| 2008 | $ 101,703 |
| 2007 | $ 92,977 |
| 2006 | $ 86,983 |
| 2005 | $79,096 |
2022: In 2022, McKesson corporation's net revenues increaseed to $263,966 million compared to $238,228 million in 2021. Its revenues increased 11% in 2022 compared to 2021.
McKesson Corporation's net revenues in 2021 increased to $238,228 million compared to $231,051 million in 2020. Its net revenues increased 3% in 2021 compared to 2020.
McKesson Corporation is one of the top ten companies in Fortune 500 list of 2022. It is an international leader in healthcare supply chain management solutions, retail pharmacy, healthcare technology, community oncology and specialty care. The company partners with life sciences companies, manufacturers, providers, pharmacies, governments and other healthcare organizations to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively.
In fiscal 2019, its net revenue grew to $214.32 billion from $208.36 bilion in 2017.